Con: Intraoperative use of nitric oxide for treatment of pulmonary hypertension in patients with congenital heart disease is not effective

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 15, Issue 2, 2001, Pages 263-264

  Russell, Isobel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Congenital heart disease; Nitric oxide; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ARTICLE; CONGENITAL HEART DISEASE; DRUG EFFICACY; HUMAN; INTRAOPERATIVE PERIOD; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; OXYGEN SATURATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASODILATATION;

EID: 0035075875     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2001.21995     Document Type: Article

References (25)

1. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
2. Molecular mechanisms of endothelium-mediated vasodilation
3. Endothelium-derived relaxing and contracting factors
4. Inhaled "endothelium-derived relaxing factor" (EDRF) in primary hypertension (PHH)
5. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
6. Inhaled nitric oxide in pulmonary hypertension after total repair of total anomalous pulmonary venous return
7. Inhaled nitric oxide: Selective pulmonary vasodilation in cardiac surgical patients
8. Inhaled nitric oxide for the adult respiratory distress syndrome
9. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
10. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide
11. Inhaled nitric oxide in congenital heart disease
12. Inhaled nitric oxide for the treatment of pulmonary hypertension before and after cardiopulmonary bypass
13. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass
14. + ion concentration changes
15. The pathophysiology of failure in acute right ventricular hypertension: Hemodynamic and biochemical correlations
16. 2 in intact-chest cat
17. Effects of nitroprusside and dopamine on pulmonary arterial vasculature in children after cardiac surgery
18. Comparison of effects of prostaglandin E1 and nitroprusside on pulmonary vascular resistance in children after open-heart surgery
19. Effects of surgical closure of ventricular septal defects upon pulmonary vascular disease
20. Surgical implications of pulmonary hypertension in congenital heart disease
21. Effects of inhaled nitric oxide in postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease
22. Diagnosis and management of postoperative pulmonary hypertensive crisis
23. The use of tolazoline hydrochloride as a pulmonary vasodilator in potentially fatal episodes of pulmonary vasoconstriction after cardiac surgery in children
24. Very-lowdose inhaled nitric oxide: A selective pulmonary vasodilator after operations for congenital heart disease
25. Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2-kg infant